Skip to content
  • Partners
  • About Us
  • Team
    • The board
    • The advisors
    • The team of executives
  • Investors
  • Values
  • Partners
  • About Us
  • Team
    • The board
    • The advisors
    • The team of executives
  • Investors
  • Values
Contact Us
  • Partners
  • About Us
  • Team
    • The board
    • The advisors
    • The team of executives
  • Investors
  • Values
  • Toggle website search
Read more about the article Stephanie O’brien

Stephanie O’brien

  • Post author:atlasstudio
  • Post published:April 26, 2023
  • Post category:

Morningside Ventures Extensive Director experience of novel science companies

Continue ReadingStephanie O’brien
Read more about the article Jaythoon Hassan

Jaythoon Hassan

  • Post author:atlasstudio
  • Post published:April 26, 2023
  • Post category:

Expert on epidemiology, outbreaks and protective immunity

Continue ReadingJaythoon Hassan
Read more about the article Andrew Exley

Andrew Exley

  • Post author:atlasstudio
  • Post published:April 26, 2023
  • Post category:

Ex-MHRA Vaccines licensing assessor

Continue ReadingAndrew Exley
Read more about the article Russ Middaugh

Russ Middaugh

  • Post author:atlasstudio
  • Post published:April 26, 2023
  • Post category:

Former Director of KU Macromolecule and Vaccine Stabilization Center. MIT & MERCK head of formulation

Continue ReadingRuss Middaugh
Read more about the article Paul Rota

Paul Rota

  • Post author:atlasstudio
  • Post published:April 26, 2023
  • Post category:

Chief of Viral Vaccines Preventable Disease Branch of CDC

Continue ReadingPaul Rota
Read more about the article Diane Griffin

Diane Griffin

  • Post author:atlasstudio
  • Post published:April 26, 2023
  • Post category:

Professor at the JHU & Global leader in virus research

Continue ReadingDiane Griffin
Read more about the article Prof Sir Andrew Pollard

Prof Sir Andrew Pollard

  • Post author:atlasstudio
  • Post published:April 26, 2023
  • Post category:

Oxford Vaccine Group, Joint Committee on Vaccination and Immunisation, WHO SAGE member

Continue ReadingProf Sir Andrew Pollard
Read more about the article Stanley Plotkin

Stanley Plotkin

  • Post author:atlasstudio
  • Post published:April 26, 2023
  • Post category:

Global Vaccine Expert

Continue ReadingStanley Plotkin
Read more about the article Patricia Massetti

Patricia Massetti

  • Post author:atlasstudio
  • Post published:April 7, 2023
  • Post category:

Commercial Director, Executive leader 13 Biopharmaceutical Product launches Merck, Sanofi, MSD

Continue ReadingPatricia Massetti
Read more about the article Beth Junker

Beth Junker

  • Post author:atlasstudio
  • Post published:April 7, 2023
  • Post category:

27 years bioprocess development & commercialization at Merck.

Continue ReadingBeth Junker
  • 1
  • 2
  • Go to the next page

Recent Comments

    MEVOX

    PROTECTION BY DESIGN
    Linkedin
    • Partners
    • About Us
    • Team
      • The board
      • The advisors
      • The team of executives
    • Investors
    • Values
    • Partners
    • About Us
    • Team
      • The board
      • The advisors
      • The team of executives
    • Investors
    • Values

    Get in touch

    contact@mevoxltd.com
    2021© • All Rights Reserved Website created by Atlas Studio